 | Up a level |
Johansson, Lars, Hockings, Paul, Frias, Juan P, Suchower, Lisa, Maaske, Jill, Iqbal, Nayyar and Wilding, John PH 
ORCID: 0000-0003-2839-8404
(2020)
DAPAGLIFLOZIN PLUS SAXAGLIPTIN ADD-ON TO METFORMIN MAINTAINS REDUCED LIVER FAT AND ADIPOSE TISSUE VOLUMES IN PATIENTS WITH TYPE 2 DIABETES OVER 122 WEEKS.
.
Johansson, Lars, Hockings, Paul D, Johnsson, Eva, Dronamraju, Nalina, Maaske, Jill, Garcia-Sanchez, Ricardo and Wilding, John PH ORCID: 0000-0003-2839-8404
(2020)
Dapagliflozin plus saxagliptin add-on to metformin reduces liver fat and adipose tissue volume in patients with type 2 diabetes.
DIABETES OBESITY & METABOLISM, 22 (7).
pp. 1094-1101.
Frias, Juan P, Maaske, Jill, Suchower, Lisa, Johansson, Lars, Hockings, Paul D, Iqbal, Nayyar and Wilding, John PH ORCID: 0000-0003-2839-8404
(2022)
Long-term effects of dapagliflozin plus saxagliptin versus glimepiride on a background of metformin in patients with type 2 diabetes: Results of a 104-week extension to a 52-week randomized, phase 3 study and liver fat MRI substudy.
DIABETES OBESITY & METABOLISM, 24 (1).
pp. 61-71.